Application 091154

Type
ANDA
Sponsor
TEVA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AMLODIPINE AND OLMESARTAN MEDOXOMILAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 5MG BASE;20MGNoNo
002AMLODIPINE AND OLMESARTAN MEDOXOMILAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 5MG BASE;40MGNoNo
003AMLODIPINE AND OLMESARTAN MEDOXOMILAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 10MG BASE;20MGNoNo
004AMLODIPINE AND OLMESARTAN MEDOXOMILAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 10MG BASE;40MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-7027Amlodipine and Olmesartan MedoxomilAmlodipine and Olmesartan MedoxomilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7027Amlodipine and Olmesartan MedoxomilAmlodipine and Olmesartan MedoxomilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7028Amlodipine and Olmesartan MedoxomilAmlodipine and Olmesartan MedoxomilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7028Amlodipine and Olmesartan MedoxomilAmlodipine and Olmesartan MedoxomilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7029Amlodipine and Olmesartan MedoxomilAmlodipine and Olmesartan MedoxomilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7029Amlodipine and Olmesartan MedoxomilAmlodipine and Olmesartan MedoxomilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7030Amlodipine and Olmesartan MedoxomilAmlodipine and Olmesartan MedoxomilTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7030Amlodipine and Olmesartan MedoxomilAmlodipine and Olmesartan MedoxomilTeva Pharmaceuticals USA, Inc.ANDACurrent
45865-901Amlodipine and Olmesartan MedoxomilAmlodipine and Olmesartan Medoxomilmedsource pharmaceuticalsANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
45700ORIG2016-10-28
9322ORIG2015-10-21